GGrantIndex
← Leaderboards

Julio David Duarte

University Of Illinois At Chicago

$5,041,679
Attributed
$6,136,298
Total exposure
4
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.9M · FY201525
$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$6,136,298 · 4

By mechanism

R01$3,908,722 · 2
T32$1,516,713 · 1
K23$710,863 · 1

Top collaborators

Most similar at University Of Illinois At Chicago

Same institution · by research overlap

Others in their field

Top investigators on “Mission

Research focus

MissionInnovationPatient PopulationPharmacogeneticsFutureHuman ResourcesResponsePreventEnsureEffectivenessAreaPatternClinical TrialsGuidelinesUnited States National Institutes Of HealthGenetic VariationResearch And DevelopmentPatient-Focused OutcomesAffectDrug PrescriptionsHealth SystemHealth Care DisparityHealth TechnologyClinical Implementation

Grant awards (13)

Training Program for Applied Research and Development in Genomic Medicine$604,541
T32 · FY2025 · HG · contact PI
Preemptive pharmacogenetic testing in medically underserved populations$830,531
R01 · FY2024 · HG · contact PI
Clinical Expansion of Precision Medicine in the Emergency Department$672,525
R01 · FY2024 · HG · contact PI
Training Program for Applied Research and Development in Genomic Medicine$357,985
T32 · FY2024 · HG · contact PI
Preemptive pharmacogenetic testing in medically underserved populations$832,870
R01 · FY2023 · HG · contact PI
Training Program for Applied Research and Development in Genomic Medicine$554,187
T32 · FY2023 · HG · contact PI
Preemptive pharmacogenetic testing in medically underserved populations$822,805
R01 · FY2022 · HG · contact PI
Preemptive pharmacogenetic testing in medically underserved populations$749,991
R01 · FY2021 · HG · contact PI
Improving treatment personalization for pulmonary hypertension associated with diastolic heart failure$180,102
K23 · FY2018 · GM · contact PI
Improving treatment personalization for pulmonary hypertension associated with diastolic heart failure$176,902
K23 · FY2017 · GM · contact PI
Improving treatment personalization for pulmonary hypertension associated with diastolic heart failure$176,902
K23 · FY2016 · GM · contact PI
Improving treatment personalization for pulmonary hypertension associated with diastolic heart failure$98,989
K23 · FY2015 · GM · contact PI
Improving treatment personalization for pulmonary hypertension associated with diastolic heart failure$77,968
K23 · FY2015 · GM · contact PI